NASDAQ:OGI OrganiGram Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding OrganiGram Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. $0.97 -0.04 (-3.96%) (As of 06/29/2022 04:00 PM ET) Add Compare Share Today's Range$0.96▼$1.0150-Day Range$0.92▼$1.5252-Week Range$0.91▼$3.13Volume1.60 million shsAverage Volume5.01 million shsMarket Capitalization$304.30 millionP/E RatioN/ADividend YieldN/APrice Target$3.43 ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive OGI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for OrganiGram and its competitors with MarketBeat's FREE daily newsletter. Email Address OGI Stock Forecast (MarketRank)Overall MarketRank™1.87 out of 5 starsMedical Sector722nd out of 1,432 stocksPharmaceutical Preparations Industry348th out of 685 stocksAnalyst Opinion: 3.3Community Rank: 4.8Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 1.3 5 -4 -3 -2 -1 - 3.3 Analyst's Opinion Consensus RatingOrganiGram has received a consensus rating of Moderate Buy. The company's average rating score is 2.57, and is based on 4 buy ratings, 3 hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $3.43, OrganiGram has a forecasted upside of 253.1% from its current price of $0.97.Amount of Analyst CoverageOrganiGram has only been the subject of 1 research reports in the past 90 days. Previous Next 4.8 Community Rank Outperform VotesOrganiGram has received 195 “outperform” votes. (Add your “outperform” vote.)Underperform VotesOrganiGram has received 79 “underperform” votes. (Add your “underperform” vote.)Community SentimentOrganiGram has received 71.17% “outperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about OrganiGram and other stocks. Vote “Outperform” if you believe OGI will outperform the S&P 500 over the long term. Vote “Underperform” if you believe OGI will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldOrganiGram does not currently pay a dividend.Dividend GrowthOrganiGram does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, OrganiGram insiders have not sold or bought any company stock.Percentage Held by InstitutionsOnly 11.78% of the stock of OrganiGram is held by institutions. Previous Next 1.3 Earnings and Valuation Earnings GrowthEarnings for OrganiGram are expected to grow in the coming year, from ($0.10) to ($0.06) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of OrganiGram is -10.78, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of OrganiGram is -10.78, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioOrganiGram has a P/B Ratio of 0.77. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About OrganiGram (NASDAQ:OGI)Organigram Holdings Inc., through its subsidiaries, produces and sells cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including cannabis flowers, cannabis oils, and vaporizers for civilian patients and veterans; adult use recreational cannabis under the Edison Cannabis Co., Trail Blazer, SHRED, SHRED'ems, Big Bag O' Buds, and Monjour brands; and cannabis edibles products and concentrates. The company also engages in the wholesale shipping of cannabis plant cuttings, dried flowers, blends, pre-rolls, and cannabis derivative based products to retailers and wholesalers for adult-use recreational cannabis. It sells its products through online, as well as telephone channels. Organigram Holdings Inc. was founded in 2013 and is headquartered in Moncton, Canada.Read More OGI Stock News HeadlinesJune 24, 2022 | benzinga.comOrganigram Reaches Proposed Settlement In 2016 Class Action - Benzinga - BenzingaJune 19, 2022 | americanbankingnews.comOrganiGram Holdings Inc. (NASDAQ:OGI) Receives $3.36 Average Price Target from AnalystsJune 7, 2022 | investing.comAs Cannabis Stocks Continue To Tank, Look At Sales Growth For Turnaround Sign - Investing.comJune 6, 2022 | finance.yahoo.comNextleaf Solutions (CSE: OILS) (OTCQB: OILFF) to Webcast Live June 7th at VirtualInvestorConferences.com - Yahoo FinanceMay 13, 2022 | benzinga.comOrganigram Q2 Fiscal 2022 Revenue Grows 117% YoY Primaraly Because Of This - Benzinga - BenzingaApril 27, 2022 | benzinga.comCantor Fitzgerald Maintains Overweight on OrganiGram Holdings, Lowers Price Target to C$3.7 - BenzingaApril 21, 2022 | nasdaq.comHappy 420 Day! Buy This Top Pot Stock Now to Celebrate Later. - NasdaqApril 20, 2022 | marketwatch.comLeafly CEO rings Nasdaq bell on cannabis holiday - MarketWatchApril 20, 2022 | fool.com3 Top Pot Stocks to Buy Right Now - The Motley FoolApril 14, 2022 | fool.comWhy OrganiGram Holdings Shares Rose 20.9% This Week - The Motley FoolApril 14, 2022 | nasdaq.com3 Steps to Claiming the $4,194 Max Monthly Social Security Benefit - NasdaqApril 14, 2022 | nasdaq.comWhy Shares in Delta Air Lines Continued Their Ascent Today - NasdaqApril 14, 2022 | finance.yahoo.comWhy OrganiGram Holdings Shares Rose 20.9% This WeekSee More Headlines Industry, Sector and Symbol Stock ExchangeNASDAQ Industry Pharmaceutical preparations Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:OGI CUSIPN/A CIK1620737 Webwww.organigram.ca Phone(844) 644-4726FaxN/AEmployees841Year FoundedN/ACompany Calendar Last Earnings4/12/2022Today6/30/2022Next Earnings (Estimated)7/12/2022Fiscal Year End8/31/2022Price Target and Rating Average Stock Price Forecast$3.43 High Stock Price Forecast$5.30 Low Stock Price Forecast$2.25 Forecasted Upside/Downside+253.1%Consensus RatingModerate Buy Rating Score (0-4)2.57142857142857 Research Coverage7 Analysts Profitability EPS (Most Recent Fiscal Year)($0.09) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-103.09 million Net Margins-32.87% Pretax Margin-34.16% Return on Equity-12.28% Return on Assets-10.75% Debt Debt-to-Equity RatioN/A Current Ratio5.04 Quick Ratio3.84 Sales & Book Value Annual Sales$62.43 million Price / Sales4.87 Cash FlowN/A Price / Cash FlowN/A Book Value$1.26 per share Price / Book0.77Miscellaneous Outstanding Shares313,708,000Free FloatN/AMarket Cap$304.30 million OptionableNot Optionable Beta0.38 OrganiGram Frequently Asked Questions Should I buy or sell OrganiGram stock right now? 7 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for OrganiGram in the last year. There are currently 3 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" OrganiGram stock. View analyst ratings for OrganiGram or view top-rated stocks. What is OrganiGram's stock price forecast for 2022? 7 Wall Street analysts have issued 12-month target prices for OrganiGram's stock. Their OGI stock forecasts range from $2.25 to $5.30. On average, they anticipate OrganiGram's share price to reach $3.43 in the next year. This suggests a possible upside of 253.1% from the stock's current price. View analysts' price targets for OrganiGram or view top-rated stocks among Wall Street analysts. How has OrganiGram's stock price performed in 2022? OrganiGram's stock was trading at $1.75 at the beginning of 2022. Since then, OGI shares have decreased by 44.6% and is now trading at $0.97. View the best growth stocks for 2022 here. When is OrganiGram's next earnings date? OrganiGram is scheduled to release its next quarterly earnings announcement on Tuesday, July 12th 2022. View our earnings forecast for OrganiGram. How were OrganiGram's earnings last quarter? OrganiGram Holdings Inc. (NASDAQ:OGI) announced its earnings results on Tuesday, April, 12th. The company reported ($0.02) earnings per share for the quarter, hitting the consensus estimate of ($0.02). The business had revenue of $25.04 million for the quarter, compared to the consensus estimate of $24.28 million. OrganiGram had a negative trailing twelve-month return on equity of 12.28% and a negative net margin of 32.87%. During the same period in the previous year, the firm posted ($0.09) earnings per share. View OrganiGram's earnings history. Who are OrganiGram's key executives? OrganiGram's management team includes the following people: Mr. Derrick W. West CPA, CPA, (CA), Chief Financial Officer (Age 55, Pay $241.86k)Ms. Helen Martin, Chief Legal Officer & Corp. Sec. (Age 44, Pay $226.53k)Mr. Gregory Engel, Special Advisor (Age 57, Pay $453.13k)Mr. Timothy Emberg, Chief Revenue OfficerMr. Paolo De Luca C.A., C.F.A, Chief Strategy Officer (Age 49, Pay $238.66k)Ms. Beena G. Goldenberg, CEO & Director (Age 59)Ms. Nathalie Batten, VP of OperationsAmy Schwalm, VP of Investor RelationsMs. Megan Amber McCrae, Sr. VP of Marketing & CommunicationsTina Shannon, VP of HR Who are some of OrganiGram's key competitors? Some companies that are related to OrganiGram include Kura Oncology (KURA), Cassava Sciences (SAVA), Reata Pharmaceuticals (RETA), Arcutis Biotherapeutics (ARQT), IVERIC bio (ISEE), Prometheus Biosciences (RXDX), 23andMe (ME), Syndax Pharmaceuticals (SNDX), BELLUS Health (BLU), Vectura Group (VEGPF), Amylyx Pharmaceuticals (AMLX), Innoviva (INVA), Revance Therapeutics (RVNC), FibroGen (FGEN) and NGM Biopharmaceuticals (NGM). View all of OGI's competitors. What other stocks do shareholders of OrganiGram own? Based on aggregate information from My MarketBeat watchlists, some companies that other OrganiGram investors own include KushCo (KSHB), (CGC), Auxly Cannabis Group (CBWTF), Supreme Cannabis (SPRWF), Medical Marijuana (MJNA), CNBX Pharmaceuticals (CNBX), MariMed (MRMD), Aurora Cannabis (ACB), EVIO (EVIO) and Gran Tierra Energy (GTE). What is OrganiGram's stock symbol? OrganiGram trades on the NASDAQ under the ticker symbol "OGI." How do I buy shares of OrganiGram? Shares of OGI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is OrganiGram's stock price today? One share of OGI stock can currently be purchased for approximately $0.97. How much money does OrganiGram make? OrganiGram (NASDAQ:OGI) has a market capitalization of $304.30 million and generates $62.43 million in revenue each year. The company earns $-103.09 million in net income (profit) each year or ($0.09) on an earnings per share basis. How many employees does OrganiGram have? OrganiGram employs 841 workers across the globe. How can I contact OrganiGram? OrganiGram's mailing address is 35 English Dr., Moncton Z4, E1E 3X3. The official website for OrganiGram is www.organigram.ca. The company can be reached via phone at (844) 644-4726. This page (NASDAQ:OGI) was last updated on 6/30/2022 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply. MarketBeat Resources Premium Research Tools MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools. Discover All Access Market Data and Calendars Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free. View Market Data Investing Education and Resources Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more. Financial Terms Details Here
